NASDAQ Stock Watchlist: INDP, EZFL, NKTR, THTX, GNSS

There are very few stock markets that can rival the NASDAQ for liquidity, trading volume, and the number of listed stocks. Hence, there is constant attention on the exchange among investors as they seek to discover the next lot of stocks to track. Here is a closer look at five NASDAQ-listed stocks that could be worth watching.

Indaptus Therapeutics Inc. (NASDAQ:INDP) Yesterday, Indaptus Therapeutics Inc. announced that it had completed the first cohort of patients who had been administered a solitary dose of INDP D101 as part of the Phase 1 trial of Decoy 20. The company further noted that it was going to initiate a new cohort after the Safety Review Committee completed the review of the data as directed in the clinical trial protocol.

The company enrolled four patients in the cohort. The patients experienced adverse events or symptoms that were only short-lived and were in line with the way Decoy 20 may work. Some of the symptoms experienced by the patients included nausea, chills, and an elevation of temperature. Some of the other transient effects included changes in blood pressure and heart rate.

The Chief Executive Officer of the company, Indaptus Therapeutics, spoke about the development as well. He noted that the enrollment of the second cohort would bring the company closer to determining the Phase 2 dose for the multi-dosage stage of the clinical trial.

EzFill Holdings Inc. (NASDAQ:EZFL) The emerging and pioneering leader in the mobile fuel industry, EzFill Holdings Inc., announced on July 10 that it had hit a record for gallons delivered in the second fiscal quarter. The company announced that over the course of that second quarter, it had delivered 1.58 million gallons. It was a quarterly record for the company, and it was the sixth straight quarter in which the company had managed to raise its gallons delivered metric. The gallons delivered figure for the second quarter reflected a sequential rise of 20% from the previous quarter, and on a year-on-year basis, it worked out to a 100% increase.

The company revealed that it had been able to deliver such a performance by adding 53 new fleet accounts in 2023 up until the date on which the news was released. Additionally, the company also opted for a marine and residence-focused marketing plan, which has begun delivering results in the form of new customers and orders. EzFill Holdings announced at the time that it was focused on the addition of new technology and features to its consumer-facing app.

Nektar Therapeutics (NASDAQ:NKTR) This week, Nektar Therapeutics was one of the many companies that announced its financial results for the second fiscal quarter, which ended on June 30, 2023. The company revealed that the combined cash and marketable securities at its disposal stood at $409.4 million. In the period ended December 31, 2022, it stood at $505 million. The company noted that its cash and marketable securities were expected to last for financing development initiatives as well as operations up until at least the middle of 2026.

Revenues dropped to $20.5 million for the quarter from $21.6 million in the prior-year period. In the first half of the year, revenues stood at $42.1 million, which was lower than the $46.4 million in the prior-year period. The total operating costs for the quarter went down significantly to $227.4 million in the half-year period, as opposed to $315.8 million in the first half of 2022.

Theratechnologies Inc. (NASDAQ:THTX) The biopharmaceutical company Theratechnologies Inc. is involved in the commercialization and development of innovative therapies. On July 31, the company announced that it had completed the consolidation of its issued and outstanding shares, as had been announced previously. The company revealed that the reverse stock split would see each block of four issued and outstanding shares in Theratechnologies turned into one share.

The move had received the necessary regulatory approvals, the company noted at the time, and that included approvals from both NASDAQ and the Toronto Stock Exchange (TSX).pproval from shareholders was not necessary for the consolidation. On July 31, 2023, the shares of Theratechnologies commenced trading on a post-consolidated basis on the NASDAQ and TSX.

Genasys Inc. (NASDAQ:GNSS) Yesterday, the protective communications solutions leader Genasys Inc. announced its financial results for the third fiscal quarter that ended on June 30, 2023. The company reported revenues of $14.3 million, as opposed to $14.2 million in the prior-year quarter.

The operating loss as per GAAP was $1.5 million, which was higher than the GAAP operating loss of $0.6 million in the corresponding quarter in 2022. The GAAP net loss per share was $0.04, as opposed to $0.02 in the prior-year quarter. The adjusted EBITDA loss came in at $0.4 million, but in the prior-year period, the company had generated an EBITDA profit of $0.4 million.